News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News HRS 2019 ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost? Todd Neale May 10, 2019
News Conference News TCT 2018 RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation Todd Neale September 26, 2018
News Conference News TCT 2018 Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation Todd Neale September 25, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Conference News ESC 2014 SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year Todd Neale September 01, 2014
News Conference News AHA 2013 Long-term Outcomes with Renal Denervation Show Sustained Benefit Yael L. Maxwell November 16, 2013
News Conference News ESC 2013 Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation Caitlin E. Cox September 04, 2013
News Conference News ESC 2012 Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension August 29, 2012
News Conference News ACC 2012 Symplicity Works: Renal Denervation Reduces Resistant Hypertension Yael L. Maxwell March 27, 2012